In Vivo and in Vitro Binding of [125I]I‐R‐(+)‐TISCH: A Dopamine D1 Receptor Ligand for Studying Pancreatic Β‐cell Mass

Yan Zhang,Guangwen Li,Yuli Sun,Haiyan Hong,Linlin Li,Yang Luo,Ran Wang,Lin Zhu,Hank F. Kung,Jinxia Zhu

DOI: https://doi.org/10.1002/jlcr.4005

2022-01-01

Journal of Labelled Compounds and Radiopharmaceuticals

Abstract:Diabetes mellitus (DM) and insulinoma are mainly affected by the status of pancreatic β‐cell mass (BCM). Development of imaging agents for BCM allows to study pancreatic β cells and the relationship between β cells and DM or insulinoma. In this study, we investigated the density of dopamine D1 receptor on the β cells and measured BCM by statistical image processing. The pancreatic uptakes of [125I]I‐R‐(+)‐7‐chloro‐8‐hydroxy‐1‐(3′‐iodopheny1)‐3‐methyl‐2,3,4,5‐tetrahydro‐1H‐3‐benzazepine ([125I]I‐R‐(+)‐TISCH), dopamine D1 receptor tracer, in normal and diabetic rats displayed significant differences at 30 min (1.11 ± 0.08% ID/g vs. 0.63 ± 0.09% ID/g, p < 0.0001). In the presence of SCH23390, the pancreatic uptake of [125I]I‐R‐(+)‐TISCH at 30 min in normal rats was lower (1.01 ± 0.04% ID/g, p < 0.05). Although the blocking was not complete, [125I]I‐R‐(+)‐TISCH showed specific binding signals to the pancreas. Furthermore, the uptakes of [125I]I‐R‐(+)‐TISCH in INS‐1 cells were reduced in the presence of SCH23390 at different concentrations. [125I]I‐R‐(+)‐TISCH displayed a respectable uptake in insulinoma. Overall, [125I]I‐R‐(+)‐TISCH provided specific binding signals to pancreatic β cells. Although the specific signal may not be sufficient for imaging in vivo, the dopamine D1 receptor can still be considered as a potential target for studying BCM. Further investigation will be required to optimize the ligand.